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Abstract
Introduction Stem cells of somatic tissues are hypothesized to
protect themselves from mutation and cancer risk through a
process of selective segregation of their template DNA strands
during asymmetric division. Mouse mammary epithelium
contains label-retaining epithelial cells that divide asymmetrically
and retain their template DNA.
Method Immunohistochemistry was used in murine mammary
glands that had been labeled with [3H]thymidine during
allometric growth to investigate the co-expression of DNA label
retention and estrogen receptor (ER)-α or progesterone
receptor (PR). Using the same methods, we investigated the co-
localization of [3H]thymidine and ER-α or PR in mammary tissue
from mice that had received treatment with estrogen,
progesterone, and prolactin subsequent to a long chase period
to identify label-retaining cells.
Results Label-retaining epithelial cells (LRECs) comprised
approximately 2.0% of the entire mammary epithelium. ER-α-
positive and PR-positive cells represented about 30–40% of the
LREC subpopulation. Administration of estrogen, progesterone,
and prolactin altered the percentage of LRECs expressing ER-
α.
Conclusion The results presented here support the premise
that there is a subpopulation of LRECs in the murine mammary
gland that is positive for ER-α and/or PR. This suggests that
certain mammary LRECs (potentially stem cells) remain stably
positive for these receptors, raising the possibility that LRECs
comprise a hierarchy of asymmetrically cycling mammary stem/
progenitor cells that are distinguished by the presence or
absence of nuclear steroid receptor expression.
Introduction
Dividing adult somatic stem cells are postulated to protect
themselves from mutation and cancer risk by segregation of
their template DNA strands through a process known as asym-
metric division [1-3]. This property is deemed to protect long-
lived stem cells from errors incurred during DNA replication
that lead to mutagenesis [2]. In the mouse mammary gland,
label-retaining epithelial cells (LRECs) in the ducts divide
asymmetrically and retain their template DNA strands [4]. In
addition, more than 80% of these LRECs remain in the cell
cycle, dividing actively as evidenced by their incorporation of a
second DNA label after a 48-hour pulse. Ductal morphogene-
sis occurs between the third and tenth weeks of age in the
mouse, during which time the mammary gland is rapidly prolif-
erating and differentiating. Mammary epithelial stem cells con-
tribute to this development of the mammary gland through
both asymmetric and symmetric division: asymmetric division
for the generation of transit-amplifying and progenitor cells
that subsequently differentiate; and symmetric division for self-
renewal and stem cell expansion. In the mature mouse the
mammary epithelium exists in a state of relative proliferative
quiescence before pregnancy. Tissue homeostasis is main-
tained by stem cells positioned throughout the mammary duc-
tal system.
The importance of estrogen-mediated and progesterone-
mediated responses for normal mammary growth and devel-
opment and during mammary carcinogenesis is well recog-
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nized [5]. Here, we examine LRECs in mouse mammary
epithelium for expression of estrogen receptor (ER)-α and PR.
We found that epithelial cells with these characteristics are
labeled during mammary ductal development, and that after a
long chase period they continue to retain both the original
DNA label and expression of PR and ER-α. This observation
suggests that a proportion of asymmetrically cycling LRECs is
permanently steroid hormone receptor positive and represents




The experimental plan was reported previously [4]. Briefly, the
experiment was begun when the FVB/N mice were exactly 32
days of age. Sixteen mice were used in each experiment. The
mice received daily intraperitoneal injections of 1.0 µg estra-
diol, followed 2 hours later by an intraperitoneal injection of
[3H]thymidine of either 25 or 50 µCu for 5 consecutive days.
Two animals were removed for tissue analysis following the
final [3H]thymidine injection to determine the number of mam-
mary cells that were labeled. The number 3, 4, 8, and 9 mam-
mary glands were collected. The small intestine from each
animal was excised and bundled to provide a positively labeled
control for autoradiography as an indicator of successful incor-
poration of the nuclear label. Subsequently, estradiol (1.0 µg)
was given every other day for 3 weeks to promote mammary
growth. Upon cessation of estradiol treatment (the ninth week
of life), the animals were held for 2 weeks; at the end of the
11th week of life, tissues were removed from two animals to
determine the number and location of long-label-retaining
mammary cells.
The remaining mice were placed in three groups and treated
as follows (daily doses given): group I received 1.0 µg estra-
diol; group II received 1.0 µg estradiol and 1.0 mg progester-
one; and group III received estradiol and progesterone (same
doses as groups I and II) plus 0.5 µg/g body weight prolactin.
Each group received 1.0 mg of 5-bromo-deoxyuridine (5BrdU)
intraperitoneally, on day 1 and day 2 of hormone treatment. All
hormone treatments were maintained for 5 consecutive days.
One animal from each group was removed for tissue analysis
after the third day of hormone treatment. The remaining ani-
mals were analyzed 3 days following the final hormone treat-
ment (6 days after the final 5BrdU injection).
The protocols and procedures used in the experiments were
reviewed and approved by the Animal Care and Use Commit-
tee at the NCI-Frederick. Housing and care during the experi-
mental period conformed to the guidlines provided by the US
National Institutes of Health.
Autoradiography and immunochemistry
All immunohistochemistry was performed after autoradio-
graphic exposure, the sections were deparaffinized and rehy-
drated, and endogenous peroxidase was inactivated with 1%
hydogen peroxide in methanol for 30 min. Antibodies used
were anti-progesterone receptor 1:75 (clone A009B; Dako
USA, Carpinteria, CA, USA) and anti-ER-α 1:50 (clone MC-
20; Santa Cruz Biotech, Santa Cruz, CA, USA). Antigen
retrieval was accomplished according to the direction of the
manufacturer. Negative tissue controls were included in all
immunohistochemical analyses. Sections were counter-
stained with hematoxylin or nuclear fast red after immunostain-
ing.
For autoradiography, 5–6 µm sections were cut, placed upon
slides, de-waxed, rehydrated through ethanol, and subse-
quently dipped in Kodak (Rochester, New York, USA) NTB-2
liquid emulsion diluted 1:1 with distilled water. After drying, the
slides were stored in lightproof slide boxes at constant humid-
ity and temperature for 20 days. After exposure, the slides
were developed in Kodak D-19, washed in distilled water, and
fixed in Kodak rapid fixer diluted 1:1 with distilled water. After
staining and mounting, the slides were observed and evalu-
ated for autoradiographic grains and for immunostaining.
Images were recorded with Kodak digital microscopy docu-
mentation system 290 and edited with Adobe Photoshop 7.0.
Determination of autoradiographic grain counts in epithelial
cells was made by counting the grains over at least 100
LRECs in sections from each of the four mammary glands
taken from each experimental mouse. At least 500 labeled
cells were counted in each of these sections. At least 3000
nuclei were examined in each slide. Examination of autoradio-
graphic slides from these tissues that were stained for PR and
ER revealed similar numbers of autoradiographic grains over
LREC nuclei.
Statistical analysis
The SigamStat software package (Systat Software, Chicago,
Illinois, USA) was used for all analyses. Data were considered
significant at P < 0.05. Representative data are presented as
mean ± standard error of the mean.
Results
To determine whether ER-α-positive and PR-positive mam-
mary epithelial cells were in cycle during allometric growth, 5-
week-old mice were injected with [3H]thymidine during the 5th
week of life for 5 days. After a 2-day pause a group was sacri-
ficed to determine the efficiency of labeling. The mammary
glands were processed for either ER-α or PR immunostaining
and [3H]thymidine. Figure 1 demonstrates that 55% of the epi-
thelial cells were in cycle, as determined by the presence of
[3H]thymidine label, and that within this group of cycling cells
31% were ER-α positive (Figure 1a) and 24% were PR posi-
tive (Figure 1b). The labeled ER-α-positive and PR-positiveAvailable online http://breast-cancer-research.com/content/8/4/R49
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cells were represented equally among the body cells of termi-
nal end buds and within the epithelium of the subtending
ducts. It is noteworthy that numerous ER-α-negative and PR-
negative cells were also labeled during the 5-day labeling
period. Numerous cells within the surrounding stroma were
also positive for [3H]thymidine incorporation (Figure 2), indi-
cating that stromal cells as well as epithelial cells were prolif-
erating in the pubertal gland.
A majority of mammary epithelial cells were labeled with
[3H]thymidine during the 5 days of allometric growth, as dem-
onstrated by the number of labeled cells. To determine
whether any of the [3H]thymidine labeled cells retained label
as well as ER-α or PR, we allowed a 6-week chase period after
the initial [3H]thymidine injections, during which duct morpho-
genesis was completed. Seven weeks after the final [3H]thy-
midine injection, animals were sacrificed and the mammary
Figure 1
ER-α-positive and PR-positive epithelial cells are in cycle in during allo- metric growth ER-α-positive and PR-positive epithelial cells are in cycle in during allo-
metric growth. (a) ER-α and [3H]thymidine are detected in mammary 
tissue. ER-α-positive staining is indicated with black arrowheads and 
[3H]thymidine incorporation is indicated with red arrowheads. (b) PR 
and [3H]thymidine are detected in mammary tissue. PR-positive stain-
ing is indicated with black arrowheads and [3H]thymidine incorporation 
is indicated with red arrowheads. (c) Graphical depiction of the number 
of cells that were double positive for [3H]thymidine incorporation and 
ER-α or PR (left scale) and the percentage of cells that were ER-α or 
PR positive within epithelium. Scale bars = 5 µm. ER, estrogen recep-
tor; PR, progesterone receptor.
Figure 2
Stromal cells proliferate in pubertal mammary tissue Stromal cells proliferate in pubertal mammary tissue. The nuclear label 
[3H]thymidine is detected in mammary tissue that has been processed 
for (a) ER-α or (b) PR. Black arrows designate stromal cells that are 
[3H]thymidine positive, indicating cells that have recently undergone 
cell cycle. Scale bars = 5 µm. ER, estrogen receptor; PR, progesterone 
receptor.Breast Cancer Research    Vol 8 No 4    Booth and Smith 
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glands processed for ER-α or PR and [3H]thymidine label (Fig- ure 3). LRECs were detected in both luminal and basal posi-
tions (about 2% of epithelial cells were LRECs). Through cell
counts we determined that 27% (about 5.4/1000 total epithe-
lial cells) of LRECs (about 21/1000) were ER-α positive and
28% (about 5.6/1000 total epithelial cells) were PR positive.
In the total epithelial population 31% (about 310/1000) were
ER-α positive whereas 32% (about 320/1000) were PR pos-
itive (Table 1). Of interest is the similarity of the relative per-
centage of labeled cells that expressed ER-α or PR after the
prolonged chase compared with the percentage of ER-α-pos-
itive and PR-positive cells found labeled after the original 5-
day labeling period. This suggests that steroid receptor posi-
tive and negative LRECs may be developed simultaneously
during allometric mammary growth. Label-retaining periductal
stromal cells were also present in sections from the chased tis-
sue (Figure 4).
In order to determine the number of LRECs that were in cycle,
5BrdU was given for 2 days. Under these conditions, most of
the LRECs (about 80%) were doubly positive for [3H]thymi-
dine and 5BrdU, indicating that they were actively in cycle [4].
Figure 3
A subpopulation of LRECs is ER-α positive or PR positive A subpopulation of LRECs is ER-α positive or PR positive. (a) ER-α and [3H]thymidine are detected in mammary tissue. LRECs that are double pos-
itive for ER-α and [3H]thymidine incorporation are indicated with black arrows. Cells that are LRECs alone are indicated with red arrowheads. (b) PR 
and [3H]thymidine are detected in mammary tissue. LRECs that are double positive for PR and [3H]thymidine incorporation are indicated with black 
arrows. Cells that are LRECs alone are indicated with red arrows. (c) Graphical depiction of the number of cells that are double positive for [3H]thy-
midine incorporation and ER-α or PR (left scale) and percentage of cells that are ER-α or PR positive within epithelium. Scale bars = 5 µm. ER, 
estrogen receptor; LREC, label-retaining epithelial cell; PR, progesterone receptor.
Table 1
Percentages of receptor positive cells in the entire epithelium
Time point Percentages
ER-α+ PR+
Week 6 28.4 ± 2.1 31.8 ± 1.4
Week 11 30.7 ± 1.35 31.6 ± 3.1
Week 11 (group I) 28.3 26.3
Week 11 (group II) 35.0 26.1
Week 11 (group III) 24.2 30.4
Week 12 (group I) 26.4 ± 5.5 25.7 ± 1.6
Week 12 (group II) 24.4 ± 1.7 24.9 ± 2.1
Week 12 (group III) 23.2 ± 2.7 24.9 ± 1.5
One thousand epithelial cells were counted in mammary gland 
sections stained for ER-α or PR. Group I animals received estradiol 
injections; group II received estradiol and progesterone; and group III 
received estradiol, progesterone, and prolactin. ER, estrogen 
receptor; PR, progesterone receptor.Available online http://breast-cancer-research.com/content/8/4/R49
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On the other hand, none of the label-retaining stromal cells
were doubly positive, indicating that they were out of cycle.
During this treatment mice were divided into three groups and
given injections of estradiol (group I), estradiol plus progester-
one (group II), or estradiol plus progesterone plus prolactin
(group III). The ratio of LRECs to total epithelium remained
unchanged in all groups. ER-α and PR staining was performed
on tissue from the third and eighth day (hormones were dis-
continued on day 5). The results indicate that following a 2-day
administration of estradiol, the percentage of LRECs that were
also ER-α positive rose to approximately 44% (P  < 0.05)
whereas the percentage of PR-positive LRECs was
unchanged (Figure 5a). The combination of estradiol plus pro-
gesterone for 2 days brought about no change in ER-α-posi-
tive LRECs but it resulted in a decrease in PR-positive LRECs
to 19% (P < 0.05). No significant changes in ER-α or PR
expression in LRECs were observed in any group III mice.
Counts performed on tissue harvested 3 days after the final
hormone treatment revealed that the combination of estradiol
and progesterone had increased expression of ER-α in LRECs
to 37% (P < 0.05) whereas estradiol plus progesterone plus
prolactin had increased ER-α expression in LRECs to 32% (P
< 0.05; Figure 5b). In mice that had received estradiol alone
the numbers of ER-α-positive LRECs were not significantly dif-
ferent from those in untreated animals. No significant changes
in the number of PR-positive LRECs were observed in any
treatment group 3 days after the final hormone treatment.
These data are summarized in Table 2. The percentage of ER-
α-positive or PR-positive cells overall among the total mam-
mary epithelium exhibited no significant alterations (Table 1).
Discussion
This study demonstrates a subset of murine mammary epithe-
lial cells that is long label retaining and expresses ER-α or the
PR. Previously, it was shown that more than 80% of LRECs
are actively traversing the cell cycle, despite retention of the
original DNA label [4]. The retention of the original DNA label
over many weeks serves to establish the validity of our conclu-
sion that the LRECs represent long-lived cells. Whether these
label-retaining cells remain ER-α and/or PR positive from their
inception through the entire chase period is not possible to
determine. Nevertheless, we observed a high percentage of
ER-α and PR positive, [3H]thymidine labeled, epithelial cells
following the original labeling period. In addition, we did not
establish whether ER-α and PR are simultaneously expressed
in these cells. Recent data indicate that the expression of
active transforming growth factor (TGF)-β1 restrains ER-α-
positive cells among the mouse mammary epithelium from
entering the cell cycle [6]. In that report ER-α, PR, and acti-
vated TGF-β1 were shown to colocalize in individual mammary
epithelial cells. This TGF-β1-mediated restraint appeared to be
differentially regulated in pubertal mice as compared with
Figure 4
Periductal stromal cells retain nuclear label Periductal stromal cells retain nuclear label. The nuclear label [3H]thy-
midine is detected in mammary tissue that has been processed for (a) 
ER-α or (b) PR following a 7-week chase period. Black arrows indicate 
periductal stromal cells that are [3H]thymidine positive. Scale bars = 5 
µm. ER, estrogen receptor; PR, progesterone receptor.
Table 2




Week 11 27.8 28.5
Group 1 early 45.0 31.1
Group 2 early 23.7 19.1
Group 3 early 29.7 24.7
Group 1 late 22.7 25.9
Group 2 late 26.1 30.8
Group 3 late 31.9 25.5
One thousand epithelial cells were counted in mammary gland 
sections stained for ER-α or PR. Group I animals received estradiol 
injections; group II received estradiol and progesterone; and group III 
received estradiol, progesterone, and prolactin. ER, estrogen 
receptor; LREC, label-retaining epithelial cell; PR, progesterone 
receptor.Breast Cancer Research    Vol 8 No 4    Booth and Smith 
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mammary tissue in adult glands, with ER-α-positive cells in
pubertal tissues showing less responsiveness to depletion of
activated TGF-β1 than ER-negative cells. This is consistent
with our observation of numerous ER-α-positive/[3H]thymi-
dine-positive epithelial cells in the mammary tissue from 5-
week-old females following a 5-day application of [3H]thymi-
dine. In addition, ectopic expression of constitutively active
TGF-β1 from the whey acidic protein promoter in mammary
epithelium during allometric growth of the glands results in
early growth senescence in mammary transplants from this tis-
sue, suggesting a derangement in epithelial stem cell self-
renewal.
These observations taken together suggest the possible exist-
ence of an ER-α-positive mammary epithelial stem/progenitor
cell. In agreement with this hypothesis, the expression of con-
stitutively active TGF-β1 in mammary alveolar progenitors dur-
ing lobulogenesis inhibits their subsequent capacity to
proliferate on transplantation into cleared mammary fat pads
[7].
Clarke and coworkers [8] recently suggested in a human
model that steroid receptor-positive cells are stem cells that
self-renew through asymmetric division and produce transit
amplifying and differentiated epithelial progeny. We demon-
strated in a murine model that LRECs divide asymmetrically
and are capable of re-populating new stem cell niches, indicat-
ing that LRECs possess stem cell qualities [4]. The associa-
tion of steroid receptors and LRECs was reported previously
[9]. In agreement with that report, we observed that approxi-
mately 50% of the epithelium is cycling during allometric
growth, as determined by label uptake. Unlike the findings
reported by Zeps and coworkers [9], we observed numerous
ER-α-negative label-retaining cells as well as ER-α-positive
LRECs. However, there were significant differences in the
labeling protocols that were used in our respective studies,
and this in all likelihood is the basis for the difference in our
individual findings. Zeps and coworkers labeled 12-week-old
mature females intensively by giving [3H]thymidine label three
times an hour apart and then sought to detect ER-α-positive
long-label-retaining cells after a 2-week chase. Under these
conditions in mature females, no ER-α-negative label-retaining
cells were observed following the chase. We labeled immature
females in their fourth week of life during active ductal growth
and elongation.
Similar to Zeps and coworkers, we found that both ER-α-pos-
itive and ER-α-negative cells were labeled in the developing
glands. Both ER-α-negative and ER-α-positive long-label-
retaining cells were present after 7–8 weeks in our study. We
believe that this is because we labeled the dividing epithelial
population continuously for 5 consecutive days during stem/
progenitor cell expansion in the growing ductal epithelium,
whereas Zeps and coworkers labeled intensively for 3 hours at
estrus in mature 12-week-old females followed by a 2-week
chase. The persistence of ER-α-positive label-retaining cells in
Figure 5
Graphical depiction of percentage of LRECs that were either ER-α positive or PR positive after hormone treatments Graphical depiction of percentage of LRECs that were either ER-α positive or PR positive after hormone treatments. All animals received [3H]thymi-
dine at 5 weeks of age. Control animals (Con; white bar) received only [3H]thymidine. After a 7-week chase group I (GrpI; black bar) received estra-
diol injections; group II (GrpII; diagonal hatches) animals received estradiol and progesterone; and group III (GrpIII; vertical hatches) received 
estradiol, progesterone, and prolactin. (a) Results after 3-day hormone treatment and (b) results obtained after 5-day hormone treatment and 2-day 
recovery period. Error bars indicate the standard error of the mean. *P < 0.05, versus Con. ER, estrogen receptor; LREC, label-retaining epithelial 
cell; PR, progesterone receptor.Available online http://breast-cancer-research.com/content/8/4/R49
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this experiment after 2 weeks may be accounted for by the
selective symmetric expansion of ER-α-positive LRECs at
estrus in the mature mammary epithelium. A further suggestion
is that ER-α-positive/PR-positive LRECs and ER-α-negative/
PR-negative LRECs may represent different subsets of long-
label-retaining stem/progenitors cells among the mammary
epithelium.
The observation that estrogen upregulates ER-α expression
without an accompanying increase in PR expression in LRECs
is novel. The animals had not received [3H]thymidine for more
than 7 weeks, precluding the formation of new LRECs by addi-
tional incorporation of label. Cellular proliferation (i.e. symmet-
ric cellular division) of ER-α-positive LRECs is a possible
explanation. It was recently reported that ER-positive cells in
monkeys proliferate in response to estrogen [10]. The mecha-
nism by which estrogen induces proliferation is through the
release of growth mediators by ER-positive cells that act in a
paracrine manner on ER-negative cells initiating the cell cycle
[11]. This cannot be the explanation in this study, because any
symmetric division of LREC would result in the diminishment
of ER-positive LRECs, not an increase. Additionally, we previ-
ously established that LRECs are in cycle, as demonstrated by
the labeling of DNA with a second label (5BrdU) that rapidly
disperses to daughter cells [4], proving that LRECs are divid-
ing asymmetrically as they remain labeled with [3H]thymidine.
Another possibility is that ER and PR initiate different signal
transduction pathways and the activation of the ER pathway
induces ER production. Potential pathways include the
mitogen-activated protein kinase and the phosphatidylinositol-
3 kinase pathways [12,13]. A study conducted in the rat indi-
cated that estradiol causes reduction in ER message and pro-
tein in vivo and in vitro in the pituitary [14], which is contrary
to our observations. These investigators demonstrated that
within the pituitary the different cell types responded differ-
ently to estradiol. It is feasible, then, that the murine mammary
epithelium responds in a manner different from that of rat pitu-
itary tissue.
Long label retention in cells may result from the presence of
originally labeled cells that went out of the cell cycle shortly
after label administration. The label-retaining stromal cells
shown in Figure 5 represent an example of this circumstance.
Label-retaining cells may be represented by cells, which
traverse the cell cycle very slowly. Alternatively, in this report,
label-retaining cells (LRECs) result from the retention of the
originally labeled DNA during asymmetric cell divisions and
passage of newly synthesized DNA to the progeny. This dis-
tinction may explain the difficulty in producing LRECs in adult
mammary tissues because asymmetrically cycling cells would
not retain the newly labeled DNA strands. This in part may
account for the observation that estradiol-stimulated mammary
tissues seldom contain ER-α-positive, [3H]thymidine-labeled
cells in studies designed to determine the location of cells
mitotically responsive to estradiol stimulation.
The present findings indicate that labeled stem cells that
formed during allometric growth of the mammary gland
express ER or PR. Furthermore ER-α and PR expression in
these stem cells is affected by estrogen and progesterone.
Conclusion
The results presented here support the premise that a subpop-
ulation of LRECs (potentially epithelial stem cells) in the
murine mammary gland is ER-α and/or PR, and that expression
of these receptors by LRECs may be modulated by exogenous
stimuli.
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